Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206546
Max Phase: Preclinical
Molecular Formula: C45H65N9O11S2
Molecular Weight: 972.20
Associated Items:
ID: ALA5206546
Max Phase: Preclinical
Molecular Formula: C45H65N9O11S2
Molecular Weight: 972.20
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2)CSCc2cccc(n2)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC1=O
Standard InChI: InChI=1S/C45H65N9O11S2/c1-25(2)16-31-39(58)50-33(18-27-10-6-5-7-11-27)41(60)48-32(17-26(3)4)40(59)51-34(19-55)42(61)54-37(44(63)52-35(20-56)45(64)65)24-67-22-29-13-8-12-28(47-29)21-66-23-36(43(62)49-31)53-38(57)30-14-9-15-46-30/h5-8,10-13,25-26,30-37,46,55-56H,9,14-24H2,1-4H3,(H,48,60)(H,49,62)(H,50,58)(H,51,59)(H,52,63)(H,53,57)(H,54,61)(H,64,65)/t30-,31-,32-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: LHDULLZLPKIFOF-MDKUUQCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 972.20 | Molecular Weight (Monoisotopic): 971.4245 | AlogP: -0.89 | #Rotatable Bonds: 13 |
Polar Surface Area: 306.38 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.35 | CX Basic pKa: 9.50 | CX LogP: -3.59 | CX LogD: -3.59 |
Aromatic Rings: 2 | Heavy Atoms: 67 | QED Weighted: 0.12 | Np Likeness Score: 0.53 |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):